Nonadherence to Hepatitis B Medicines Increases Risk of Hepatocellular Carcinoma, Cirrhosis and Mortality

Recent scientific data revealed that the nonadherence to hepatitis B medicines increases the risk for hepatocellular carcinoma and cirrhosis followed by mortality.
Neung Hwa Park, MD, PhD, from the University of Ulsan College of Medicine in the Republic of Korea said,“Adherence appears to be a key factor in minimizing [liver-related events (LRE); Considering that poor adherence increased the risk of LREs in this study, identifying an effective medical strategy to improve adherence to medication may substantially improve clinical outcomes.”
The observational study was conducted among 894 chronic HBV patients who were given Baraclude (entecavir, Bristol-Myers Squibb) treatment for 10 years. After 10 years, only 296 patients had complete adherence; 617 patients had adherence rates lower or equal to 90%; 183 patients had between 70% to 90% adherence rates and 94 patients had adherence rate lower than 70%.
The results also showed that people younger 30 years and older than 70 years, had good adherence to medication.
Patients whose adherence was 90% or more had significantly higher rates of virologic response, compared to those whose adherence rates were less than 90%. People with low adherence showed higher risks for hepatocellular carcinoma, liver-related mortality and all-cause mortality by 2.9 fold, 14.3 fold and 5 fold respectively.
The research team further stated, “Sustained HBV viral suppression produces clinical benefits through preventing disease progression, reducing hepatic decompensation and by preventing HCC development in patients with [chronic HBV].”
“Antiviral resistance was the primary reason for treatment failure in the good adherence group, and poor adherence to medication was the primary reason for treatment failure in the poor adherence group.”

The post Nonadherence to Hepatitis B Medicines Increases Risk of Hepatocellular Carcinoma, Cirrhosis and Mortality appeared first on Drugdu.com
from Drugdu  https://goo.gl/QgQoHk

评论

发表评论

此博客中的热门博文

The future of lung function tests for COPD

With the global increase of  lung diseases  such as asthma, severe bronchitis and emphysema,  lung function tests  are becoming a bigger concern for many people. Spirometry  (measuring lung function) is the most well know  pulmonary function test  and vital to diagnose  COPD . Some of the diseases which can be detected are: 1. Chronic obstructive pulmonary disease (COPD) – main term used to describe lung diseases such as asthma, emphysema, chronic bronchitis etc. 2. Asthma – common and long-term lung disease characterised by coughing, shortness of breath or wheezing. 3. Chronic bronchitis – bronchial tubes become inflamed and produce an excessive amount of mucus. 4. Emphysema – long-term progressive disease where alveoli in the lungs become inflamed causing shortness of breath. 5. Cystic fibrosis – genetic lung disease characterised by frequent lung infections and coughing up mucus as a result of this. 6. Pulmonary fibrosis - interstitial lungdiseases resulting in the
阅读全文

Consumption of Crickets Support the Growth of Beneficial Gut Bacteria

图片
Valerie Stull, a doctoral graduate from the University of Wisconsin-Madison Nelson Institute for Environmental Studies published the results of her study on the benefits of consuming crickets on gut bacteria in the journal  Scientific Reports.  It is not only safe at high doses but may also reduce inflammation in the body Valerie Stull said that she was 12 when she ate her first insect. She said,  “I was on a trip with my parents in Central America and we were served fried ants; I remember being so grossed out initially, but when I put the ant in my mouth, I was really surprised because it tasted like food — and it was good!” Stull further added,  “There is a lot of interest right now in edible insects; It’s gaining traction in Europe and in the U.S. as a sustainable, environmentally friendly protein source compared to traditional livestock.” Tiffany Weir, the co-corresponding author and a professor of food science and human nutrition at Colorado State University said,  “Thi
阅读全文

Press Conference for Ddu Credit Verification Launch

According to official Ddu news, the leading global pharmaceutical and medical device B2B online platform and SGS-CSTC (Standards Technical Services Co., Ltd.) will be calling a press conference in Shenzhen, China, on August 18, 2017 to launch their strategic partnership on credit verification and kick off the Ddu Credit Verification Service officially. In recent years, the cross-border medical trade in China has seen rapid development, however due to certain factors such as lack of integrity, time lags and remote regions, it has been difficult for buyers and suppliers to determine the quality of the trade which could lead to contract fraud, counterfeit and inferior goods as well as payment delinquencies and false transaction. To tackle these problems, a signing ceremony for strategic cooperation on credit verification will be held by Ddu and SGS-CSTC to officially launch the project. Yuan Shimin, CEO of Ddu, together with high priority members across the country, will gather to
阅读全文